Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
Gespeichert in:
| Veröffentlicht in: | Blood cancer journal (New York) 2020-05, Vol.10 (5), p.58-58, Article 58 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 58 |
|---|---|
| container_issue | 5 |
| container_start_page | 58 |
| container_title | Blood cancer journal (New York) |
| container_volume | 10 |
| creator | Mina, Roberto Belotti, Angelo Petrucci, Maria Teresa Zambello, Renato Capra, Andrea Di Lullo, Giacomo Ronconi, Sonia Pescosta, Norbert Grasso, Mariella Monaco, Federico Cellini, Claudia Gobbi, Marco Ballanti, Stelvio de Fabritiis, Paolo Mosca-Siez, Maria Letizia Marchetti, Monia Liberati, Anna Marina Offidani, Massimo Giuliani, Nicola Ria, Roberto Musto, Pellegrino Romano, Alessandra Sonneveld, Pieter Boccadoro, Mario Larocca, Alessandra |
| description | |
| doi_str_mv | 10.1038/s41408-020-0326-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7234990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2404637667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-e45b11774485e0701438fe7bdad55204a7dda06534c46a7334cda29e6e160b883</originalsourceid><addsrcrecordid>eNp1kstuFDEQRVsIRKKQD2CDLLFh08SvfrFAgojHSJHYwNqqbtdkHPnR2O4RnW_j43CYJAQkvClL9_i6qnSr6jmjrxkV_VmSTNK-ppzWVPC2Zo-qY06lrBvRN48f3I-q05SuaDlNywY2PK2OBJdcskYeVz_fh5jxOjgz1hp_gMO8gxQ8EkjEgfEZPfgJSd5hhHklIRKEaFcSMUeE7NBnApmMJkw7dGYCWyQLc0Kyx5iWRMKYMO4hm-CJ8XeqPou4jTDlEFfiFpvNbJG4FW1wQOaCF-f0hgCJ4HVp8Bo1mUtzSDYbkvKi12fVky3YhKe39aT69vHD1_PP9cWXT5vzdxf1JDuaa5TNyFjXSdk3SDvKpOi32I0adNOUNUGnNdC2EXKSLXSiVA18wBZZS8e-FyfV24PvvIwO9VQai2DVHI2DuKoARv2teLNTl2GvOi7kMNBi8OrWIIbvC6asnEkTWgsew5IUl1S2omvbrqAv_0GvwhJ9Ge83JRhveFsodqCmGFIqi7xvhlF1Ew91iIcq8VA38VCsvHnxcIr7F3dhKAA_AKlI_hLjn6__7_oLaPnK-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404312526</pqid></control><display><type>article</type><title>Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Mina, Roberto ; Belotti, Angelo ; Petrucci, Maria Teresa ; Zambello, Renato ; Capra, Andrea ; Di Lullo, Giacomo ; Ronconi, Sonia ; Pescosta, Norbert ; Grasso, Mariella ; Monaco, Federico ; Cellini, Claudia ; Gobbi, Marco ; Ballanti, Stelvio ; de Fabritiis, Paolo ; Mosca-Siez, Maria Letizia ; Marchetti, Monia ; Liberati, Anna Marina ; Offidani, Massimo ; Giuliani, Nicola ; Ria, Roberto ; Musto, Pellegrino ; Romano, Alessandra ; Sonneveld, Pieter ; Boccadoro, Mario ; Larocca, Alessandra</creator><creatorcontrib>Mina, Roberto ; Belotti, Angelo ; Petrucci, Maria Teresa ; Zambello, Renato ; Capra, Andrea ; Di Lullo, Giacomo ; Ronconi, Sonia ; Pescosta, Norbert ; Grasso, Mariella ; Monaco, Federico ; Cellini, Claudia ; Gobbi, Marco ; Ballanti, Stelvio ; de Fabritiis, Paolo ; Mosca-Siez, Maria Letizia ; Marchetti, Monia ; Liberati, Anna Marina ; Offidani, Massimo ; Giuliani, Nicola ; Ria, Roberto ; Musto, Pellegrino ; Romano, Alessandra ; Sonneveld, Pieter ; Boccadoro, Mario ; Larocca, Alessandra</creatorcontrib><identifier>ISSN: 2044-5385</identifier><identifier>EISSN: 2044-5385</identifier><identifier>DOI: 10.1038/s41408-020-0326-1</identifier><identifier>PMID: 32424154</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/2779/109/1941 ; 692/699/67/1990/804 ; Aged ; Antineoplastic Agents - therapeutic use ; Biomedical and Life Sciences ; Biomedicine ; Bortezomib - therapeutic use ; Cancer Research ; Correspondence ; Dexamethasone - therapeutic use ; Female ; Hematology ; Humans ; Male ; Multiple Myeloma - drug therapy ; Neoplasm Recurrence, Local - drug therapy ; Oncology ; Survival Analysis</subject><ispartof>Blood cancer journal (New York), 2020-05, Vol.10 (5), p.58-58, Article 58</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-e45b11774485e0701438fe7bdad55204a7dda06534c46a7334cda29e6e160b883</citedby><cites>FETCH-LOGICAL-c470t-e45b11774485e0701438fe7bdad55204a7dda06534c46a7334cda29e6e160b883</cites><orcidid>0000-0002-2070-3702 ; 0000-0002-8144-541X ; 0000-0002-1515-0090</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234990/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234990/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,41099,42168,51554,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32424154$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mina, Roberto</creatorcontrib><creatorcontrib>Belotti, Angelo</creatorcontrib><creatorcontrib>Petrucci, Maria Teresa</creatorcontrib><creatorcontrib>Zambello, Renato</creatorcontrib><creatorcontrib>Capra, Andrea</creatorcontrib><creatorcontrib>Di Lullo, Giacomo</creatorcontrib><creatorcontrib>Ronconi, Sonia</creatorcontrib><creatorcontrib>Pescosta, Norbert</creatorcontrib><creatorcontrib>Grasso, Mariella</creatorcontrib><creatorcontrib>Monaco, Federico</creatorcontrib><creatorcontrib>Cellini, Claudia</creatorcontrib><creatorcontrib>Gobbi, Marco</creatorcontrib><creatorcontrib>Ballanti, Stelvio</creatorcontrib><creatorcontrib>de Fabritiis, Paolo</creatorcontrib><creatorcontrib>Mosca-Siez, Maria Letizia</creatorcontrib><creatorcontrib>Marchetti, Monia</creatorcontrib><creatorcontrib>Liberati, Anna Marina</creatorcontrib><creatorcontrib>Offidani, Massimo</creatorcontrib><creatorcontrib>Giuliani, Nicola</creatorcontrib><creatorcontrib>Ria, Roberto</creatorcontrib><creatorcontrib>Musto, Pellegrino</creatorcontrib><creatorcontrib>Romano, Alessandra</creatorcontrib><creatorcontrib>Sonneveld, Pieter</creatorcontrib><creatorcontrib>Boccadoro, Mario</creatorcontrib><creatorcontrib>Larocca, Alessandra</creatorcontrib><title>Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study</title><title>Blood cancer journal (New York)</title><addtitle>Blood Cancer J</addtitle><addtitle>Blood Cancer J</addtitle><subject>692/308/2779/109/1941</subject><subject>692/699/67/1990/804</subject><subject>Aged</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bortezomib - therapeutic use</subject><subject>Cancer Research</subject><subject>Correspondence</subject><subject>Dexamethasone - therapeutic use</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Male</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Neoplasm Recurrence, Local - drug therapy</subject><subject>Oncology</subject><subject>Survival Analysis</subject><issn>2044-5385</issn><issn>2044-5385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kstuFDEQRVsIRKKQD2CDLLFh08SvfrFAgojHSJHYwNqqbtdkHPnR2O4RnW_j43CYJAQkvClL9_i6qnSr6jmjrxkV_VmSTNK-ppzWVPC2Zo-qY06lrBvRN48f3I-q05SuaDlNywY2PK2OBJdcskYeVz_fh5jxOjgz1hp_gMO8gxQ8EkjEgfEZPfgJSd5hhHklIRKEaFcSMUeE7NBnApmMJkw7dGYCWyQLc0Kyx5iWRMKYMO4hm-CJ8XeqPou4jTDlEFfiFpvNbJG4FW1wQOaCF-f0hgCJ4HVp8Bo1mUtzSDYbkvKi12fVky3YhKe39aT69vHD1_PP9cWXT5vzdxf1JDuaa5TNyFjXSdk3SDvKpOi32I0adNOUNUGnNdC2EXKSLXSiVA18wBZZS8e-FyfV24PvvIwO9VQai2DVHI2DuKoARv2teLNTl2GvOi7kMNBi8OrWIIbvC6asnEkTWgsew5IUl1S2omvbrqAv_0GvwhJ9Ge83JRhveFsodqCmGFIqi7xvhlF1Ew91iIcq8VA38VCsvHnxcIr7F3dhKAA_AKlI_hLjn6__7_oLaPnK-g</recordid><startdate>20200518</startdate><enddate>20200518</enddate><creator>Mina, Roberto</creator><creator>Belotti, Angelo</creator><creator>Petrucci, Maria Teresa</creator><creator>Zambello, Renato</creator><creator>Capra, Andrea</creator><creator>Di Lullo, Giacomo</creator><creator>Ronconi, Sonia</creator><creator>Pescosta, Norbert</creator><creator>Grasso, Mariella</creator><creator>Monaco, Federico</creator><creator>Cellini, Claudia</creator><creator>Gobbi, Marco</creator><creator>Ballanti, Stelvio</creator><creator>de Fabritiis, Paolo</creator><creator>Mosca-Siez, Maria Letizia</creator><creator>Marchetti, Monia</creator><creator>Liberati, Anna Marina</creator><creator>Offidani, Massimo</creator><creator>Giuliani, Nicola</creator><creator>Ria, Roberto</creator><creator>Musto, Pellegrino</creator><creator>Romano, Alessandra</creator><creator>Sonneveld, Pieter</creator><creator>Boccadoro, Mario</creator><creator>Larocca, Alessandra</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2070-3702</orcidid><orcidid>https://orcid.org/0000-0002-8144-541X</orcidid><orcidid>https://orcid.org/0000-0002-1515-0090</orcidid></search><sort><creationdate>20200518</creationdate><title>Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study</title><author>Mina, Roberto ; Belotti, Angelo ; Petrucci, Maria Teresa ; Zambello, Renato ; Capra, Andrea ; Di Lullo, Giacomo ; Ronconi, Sonia ; Pescosta, Norbert ; Grasso, Mariella ; Monaco, Federico ; Cellini, Claudia ; Gobbi, Marco ; Ballanti, Stelvio ; de Fabritiis, Paolo ; Mosca-Siez, Maria Letizia ; Marchetti, Monia ; Liberati, Anna Marina ; Offidani, Massimo ; Giuliani, Nicola ; Ria, Roberto ; Musto, Pellegrino ; Romano, Alessandra ; Sonneveld, Pieter ; Boccadoro, Mario ; Larocca, Alessandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-e45b11774485e0701438fe7bdad55204a7dda06534c46a7334cda29e6e160b883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>692/308/2779/109/1941</topic><topic>692/699/67/1990/804</topic><topic>Aged</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bortezomib - therapeutic use</topic><topic>Cancer Research</topic><topic>Correspondence</topic><topic>Dexamethasone - therapeutic use</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Male</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Neoplasm Recurrence, Local - drug therapy</topic><topic>Oncology</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mina, Roberto</creatorcontrib><creatorcontrib>Belotti, Angelo</creatorcontrib><creatorcontrib>Petrucci, Maria Teresa</creatorcontrib><creatorcontrib>Zambello, Renato</creatorcontrib><creatorcontrib>Capra, Andrea</creatorcontrib><creatorcontrib>Di Lullo, Giacomo</creatorcontrib><creatorcontrib>Ronconi, Sonia</creatorcontrib><creatorcontrib>Pescosta, Norbert</creatorcontrib><creatorcontrib>Grasso, Mariella</creatorcontrib><creatorcontrib>Monaco, Federico</creatorcontrib><creatorcontrib>Cellini, Claudia</creatorcontrib><creatorcontrib>Gobbi, Marco</creatorcontrib><creatorcontrib>Ballanti, Stelvio</creatorcontrib><creatorcontrib>de Fabritiis, Paolo</creatorcontrib><creatorcontrib>Mosca-Siez, Maria Letizia</creatorcontrib><creatorcontrib>Marchetti, Monia</creatorcontrib><creatorcontrib>Liberati, Anna Marina</creatorcontrib><creatorcontrib>Offidani, Massimo</creatorcontrib><creatorcontrib>Giuliani, Nicola</creatorcontrib><creatorcontrib>Ria, Roberto</creatorcontrib><creatorcontrib>Musto, Pellegrino</creatorcontrib><creatorcontrib>Romano, Alessandra</creatorcontrib><creatorcontrib>Sonneveld, Pieter</creatorcontrib><creatorcontrib>Boccadoro, Mario</creatorcontrib><creatorcontrib>Larocca, Alessandra</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood cancer journal (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mina, Roberto</au><au>Belotti, Angelo</au><au>Petrucci, Maria Teresa</au><au>Zambello, Renato</au><au>Capra, Andrea</au><au>Di Lullo, Giacomo</au><au>Ronconi, Sonia</au><au>Pescosta, Norbert</au><au>Grasso, Mariella</au><au>Monaco, Federico</au><au>Cellini, Claudia</au><au>Gobbi, Marco</au><au>Ballanti, Stelvio</au><au>de Fabritiis, Paolo</au><au>Mosca-Siez, Maria Letizia</au><au>Marchetti, Monia</au><au>Liberati, Anna Marina</au><au>Offidani, Massimo</au><au>Giuliani, Nicola</au><au>Ria, Roberto</au><au>Musto, Pellegrino</au><au>Romano, Alessandra</au><au>Sonneveld, Pieter</au><au>Boccadoro, Mario</au><au>Larocca, Alessandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study</atitle><jtitle>Blood cancer journal (New York)</jtitle><stitle>Blood Cancer J</stitle><addtitle>Blood Cancer J</addtitle><date>2020-05-18</date><risdate>2020</risdate><volume>10</volume><issue>5</issue><spage>58</spage><epage>58</epage><pages>58-58</pages><artnum>58</artnum><issn>2044-5385</issn><eissn>2044-5385</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32424154</pmid><doi>10.1038/s41408-020-0326-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-2070-3702</orcidid><orcidid>https://orcid.org/0000-0002-8144-541X</orcidid><orcidid>https://orcid.org/0000-0002-1515-0090</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2044-5385 |
| ispartof | Blood cancer journal (New York), 2020-05, Vol.10 (5), p.58-58, Article 58 |
| issn | 2044-5385 2044-5385 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7234990 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | 692/308/2779/109/1941 692/699/67/1990/804 Aged Antineoplastic Agents - therapeutic use Biomedical and Life Sciences Biomedicine Bortezomib - therapeutic use Cancer Research Correspondence Dexamethasone - therapeutic use Female Hematology Humans Male Multiple Myeloma - drug therapy Neoplasm Recurrence, Local - drug therapy Oncology Survival Analysis |
| title | Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A19%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bortezomib-dexamethasone%20as%20maintenance%20therapy%20or%20early%20retreatment%20at%20biochemical%20relapse%20versus%20observation%20in%20relapsed/refractory%20multiple%20myeloma%20patients:%20a%20randomized%20phase%20II%20study&rft.jtitle=Blood%20cancer%20journal%20(New%20York)&rft.au=Mina,%20Roberto&rft.date=2020-05-18&rft.volume=10&rft.issue=5&rft.spage=58&rft.epage=58&rft.pages=58-58&rft.artnum=58&rft.issn=2044-5385&rft.eissn=2044-5385&rft_id=info:doi/10.1038/s41408-020-0326-1&rft_dat=%3Cproquest_pubme%3E2404637667%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2404312526&rft_id=info:pmid/32424154&rfr_iscdi=true |